Kiniksa Pharmaceuticals International, plc Ratios

Ratios Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 76.39%-128.95%87.64%85.61%
EBT Margin -426.22%950.93%-33.72%-8.54%
EBIT Margin -406.38%97.73%-9.32%-10.78%
EBITDA Margin -409.81%1,834.73%5.20%-10.25%
Operating Margin -406.38%97.73%-9.32%-10.78%
Net Margin -429.82%2,674.30%-22.35%-10.21%
FCF Margin -328.75%57.02%4.87%6.00%
Efficiency
Inventory Average 12.64M26.36M28.74M
Assets Average 346.24M493.00M553.44M
Equity Average 290.59M417.49M438.64M
Invested Capital 185.04M396.15M438.84M438.44M
Asset Utilization Ratio 0.030.550.76
Leverage & Solvency
Equity Ratio 0.790.860.830.76
Valuation
Enterprise Value 1,389.51M1,091.51M1,202.89M628.62M850.98M1,027.36M1,184.52M
Market Capitalization 1,389.51M1,091.51M1,202.89M810.82M1,041.59M1,233.73M1,428.15M
Return Ratios
Return on Sales -4.30%26.74%-0.22%-0.10%
Return on Capital Employed 0.03%-0.06%-0.10%
Return on Invested Capital -0.04%
Return on Assets 0.77%-0.12%-0.08%
Return on Equity 0.92%-0.14%-0.10%